Evidence map›Paper›PMID 23585151›Full record

ArticleOtolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery2013

Head and neck cancer stem cells: the effect of HPV--an in vitro and mouse study.

Alice L Tang, John H Owen, Samantha J Hauff, Jung Je Park, Silvana Papagerakis, Carol R Bradford, Thomas E Carey, Mark E Prince

Open access · greenAbstract readComparative Study
In one paragraph

Article in Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Cannot Target What Cannot Be Seen: Molecular Imaging of Cancer Stem Cells.International journal of molecular sciences · 2023
    Review
  3. Review
  4. HPVTranslational oncology · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Environmental exposures, stem cells, and cancer.Pharmacology & therapeutics · 2019
    Review
  9. Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPVClinical cancer research : an official journal of the American Association for Cancer Research · 2019
    Article
  10. [Invasion and metastasis mechanism of human papillomavirus in head and neck squamous cell carcinomas].Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology · 2018
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Alice L TangDepartment of Otolaryngology/Head and Neck Surgery, University of Michigan, Ann Arbor, Michigan 48109, USA.
John H Owen
Samantha J Hauff
Jung Je Park
Silvana Papagerakis
Carol R Bradford
Thomas E Carey
Mark E Prince
University of Michigan–Ann Arbor · USGyeongsang National University · KRUniversity of California, San Diego · USUniversity of Cincinnati · US

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Scott Michael Schuetze · 1988 to 2026
$178.2M
Therapeutic Potential and Mechanism of Action of Potent Small Molecule InhibitorsP50CA097248 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI NOR, JACQUES EDUARDO · 2002 to 2013
$25.3M
Scientific Synergy CoreP30DC005188 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ALTSCHULER, RICHARD A · 2002 to 2016
$10.3M
Advanced Research Training in OtolaryngologyT32DC005356 · NIDCD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CORFAS, GABRIEL · 2002 to 2021
$3.5M
Biomarkers to Guide Treatment and Improve Survival in Oral/Oropharyngeal CancerR01DE019126 · NIDCR · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CAREY, THOMAS E. · 2009 to 2012
$1.4M
NCI NIH HHS P30 CA046592NCI NIH HHS P30 CA46592NCI NIH HHS P50 CA097248NCI NIH HHS P50 CA97248NIDCD NIH HHS 5 T32 DC005356NIDCD NIH HHS P30 DC005188NIDCD NIH HHS P30 DC05188NIDCD NIH HHS T32 DC005356NIDCR NIH HHS 1 R01-DE019126NIDCR NIH HHS R01 DE019126
6 · The paper itself

Abstract

objectivesTo determine if the behavior of cancer stem cells (CSCs) is affected by human papillomavirus (HPV) status. STUDY

designAn in vitro and in vivo analysis of HPV and CSCs.

settingUniversity laboratory. SUBJECTS AND

methodsWe isolated CSCs from HPV-positive and HPV-negative cell lines. Two HPV-negative cell lines underwent lentiviral transduction of E6/E7. Chemoresistence was determined using colony formation assays. Native HPV-positive and HPV E6/E7-transduced cells were compared for lung colonization after tail vein injection in NOD/SCID mice.

resultsThe proportion of CSC is not significantly different in HPV-positive or HPV-negative head and neck squamous cell carcinoma (HNSCC) cell lines. The HNSCC CSCs are more resistant to cisplatin than the non-CSCs, but there were no significant differences between HPV-positive and HPV-negative cells. The HPV-negative cancer cells yielded low colony formation after cell sorting. After transduction with HPV E6/E7, increased colony formation was observed in both CSCs and non-CSCs. Results from tail vein injections yielded no differences in development of lung colonies between HPV E6/E7-transduced cells and nontransduced cells.

conclusionsHuman papillomavirus status does not correlate with the proportion of CSCs present in HNSCC. The HPV-positive cells and those transduced with HPV E6/E7 have a greater clonogenicity than HPV-negative cells. The HNSCC CSCs are more resistant to cisplatin than non-CSCs. This suggests that common chemotherapeutic agents may shrink tumor bulk by eliminating non-CSCs, whereas CSCs have mechanisms that facilitate evasion of cell death. Human papillomavirus status does not affect CSC response to cisplatin therapy, suggesting that other factors explain the better outcomes for patients with HPV-positive cancer.

Indexed as

AnimalsCell Line, TumorHead and Neck NeoplasmsHuman papillomavirus 16HumansMiceMice, Inbred NODMice, SCIDNeoplasms, ExperimentalNeoplastic Stem CellsPapillomavirus InfectionsALDHcancer stem cellschemotherapyhead and neck cancerHPV

Identifiers

PMID23585151
PMCPMC4086879
OpenAlexW2010764484

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.